公开(公告)号：US08846023B2

公开(公告)日：2014-09-30

申请号：US14021686

申请日：2013-09-09

Applicant: Bristol-Myers Squibb Company

Inventor： Carol Bachand ,  Makonen Belema ,  Daniel H. Deon ,  Andrew C. Good ,  Jason Goodrich ,  Clint A. James ,  Rico Lavoie ,  Omar D. Lopez ,  Alain Martel ,  Nicholas A. Meanwell ,  Van N. Nguyen ,  Jeffrey Lee Romine ,  Edward H. Ruediger ,  Lawrence B. Snyder ,  Denis R. St. Laurent ,  Fukang Yang ,  David R. Langley ,  Gan Wang ,  Lawrence G. Hamann

IPC: C07D403/14 ,  C07D405/14 ,  C07D417/14 ,  A61K31/506 ,  A61K31/4178 ,  A61K31/427 ,  A61K31/13 ,  A61K31/7105 ,  A61K31/4745 ,  A61K31/7056 ,  A61K38/20 ,  A61K38/21 ,  C07D401/14

CPC classification number: A61K31/506 ,  A61K31/13 ,  A61K31/4178 ,  A61K31/427 ,  A61K31/4745 ,  A61K31/7056 ,  A61K31/7105 ,  A61K38/2013 ,  A61K38/204 ,  A61K38/208 ,  A61K38/21 ,  A61K38/212 ,  C07D401/14 ,  C07D403/14 ,  C07D405/14 ,  C07D417/14

Abstract: The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.